Articles from Adverse Event Reporting News (October 8, 2007)

1-37 out of 37 article(s)

Title	Author	Type	Words
Advertising risk guidance seen by January.	Reid, Ken		370
AHRQ, FDA to collaborate in largest-ever study of heart risks with ADHD medications.			633
Americans confused about FDA and drug safety.		Survey	719
Baxa recalls pharmacy software.		Brief article	80
Defibrillators recalled due to faulty display.		Brief article	105
Dietary supplements recalled due to harmful ingredients.		Brief article	135
Drug companies will conduct tests to spot side effect risks.			369
EU to consider greater warnings for anemia drugs.		Brief article	193
Exl Pharma Pharmacovigilance Summit 2007: developing and implementing compliant strategies to minimize the risk of adverse drug reactions and increase drug safety--Dec. 3-4, 2007, Loews Philadelphia Hotel, Philadelphia, PA.			100
Expertbriefings.com: simplifying IT change control, Oct. 11, 2-3pm (EDT).			56
FDA amendments give agency broad powers over drug safety, ad fines.			357
FDA committees recommend continued U.S. marketing of Trasylol.		Brief article	171
FDA finds no links between bone-building drugs and heart problems.			369
FDA may allow more drugs to be sold without prescription.			409
FDA safety reviewers want warnings on cold medicines for kids.			525
FDA takes action to stop marketing of unapproved hydrocodone products.			540
FDA transforming CDER in response to IOM report.		Brief article	284
FDA warns of potential serious side effects with Cephalon's cancer drug.			369
FDA's Woodcock honored by Alliance.		Brief article	149
FDA, Bayer issue letter to doctors about MRI agents.		Brief article	210
Francis named Deputy Director of Office of Surveillance and Epidemiology.		Brief article	206
Galson named Acting Surgeon General; Woodcock goes back to CDER.		Brief article	259
Health Canada withdraws market authorization for Prexige.		Brief article	234
Lilly adds strong warning label to Zyprexa.			635
Mayo Clinic study finds FDA warning against droperidol unnecessary.			569
Misinformation about hormone therapy remains high.		Survey	542
Monroe named director, Division of Reproductive and Urologic Products.		Brief article	192
New warnings added to label for haloperidol.		Brief article	148
Nominations sought for Reagan-Udall Foundation.			321
Pennsylvania agency releases advisory on common causes of medication errors.			791
Pfizer warns of risks in using Viracept in pregnant, pediatric patients.		Brief article	235
Potency specifications for thyroid drugs tightened.			551
Premiere issue of FDA Drug Safety Newsletter released.		Brief article	242
SAEs, related deaths more than double from '98-'05, outpacing scrips written.			550
Salerno named to head IOM.			463
Study shows Actos reduces risk of death, heart attack and stroke, but increases risk of heart failure.			463
Ultrasound drugs face black-box warning.			385